Advertisement

Topics

PARP Inhibitor Offers Improved Quality of Life in Advanced Breast Cancer

06:25 EDT 15 Sep 2018 | Cancer Networks

Treatment with talazoparib improved quality of life vs physician’s choice of chemotherapy in patients with HER2-negative advanced breast cancer.

Original Article: PARP Inhibitor Offers Improved Quality of Life in Advanced Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "PARP Inhibitor Offers Improved Quality of Life in Advanced Breast Cancer"

Advertisement
Quick Search
Advertisement
Advertisement